Pharmaceutical companies are doing everything in their power to avoid disruption to the supply of medicines in all Brexit scenarios. This includes increasing stocks of medicine in the UK, changing supply routes, transferring medicine licenses and duplicating testing in the EU.
Vaccination has saved more lives and prevented more serious diseases than any advance in recent medical history. Every year, 2 – 3 million lives are saved across the world because of immunisation.
The UK has robust measures in place to ensure that medicines and vaccines are both clinically and cost effective before they can be used in the NHS.
Illness never sleeps. It grows, mutates and causes pain and suffering. Disease never takes a break, so neither do we. Because people fighting disease deserve the best chance to live. We won’t rest until people around the world see a brighter tomorrow.
The UK should aspire to nothing less than a health and care system that delivers the best patient outcomes in the world. We believe that a strong partnership between NHS and industry is the best way to improve outcomes for patients now and in the future.
Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.
14 May 2019
The ABPI responded to Radio 4's File on Four programme on opioids, which examined whether there are any similarities between the way in which opioid medications are being marketed by pharmaceutical companies in the US and the UK.
03 May 2019
Haseeb Ahmad, Managing Director, UK, Ireland & Nordics Novartis Pharmaceuticals and Country President Novartis UK has been confirmed as the new President of the ABPI.
02 May 2019
The Government will today announce at the ABPI Conference that the most promising treatments will be fast-tracked by the new and boosted Accelerated Access Collaborative. Medicines, technologies and diagnostic tools targeting key health problems will be prioritised. The ABPI welcomes the move.
02 May 2019
Life sciences is among a select group of highly innovative industries linked to science and tech which could be responsible for a new wave of growth worth an extra £14 billion a year to the UK economy by 2025.
17 April 2019
The ABPI sponsors the Andrew Blake Tribute Award, which recognises the significant contributions of animal technologists to improving laboratory animal welfare. This year we congratulate Stephen Woodley and Stuart Newman for winning the 2019 Award.
21 March 2019
The ABPI and Health Innovation Manchester were shortlisted for ‘Best Pharmaceutical Partnership’ in the HSJ partnership awards last night. Partnership working with the NHS is the way forward, says ABPI Chief Executive Mike Thompson.